Investing in Avantor, Inc. (AVTR)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)5.11-76
Intrinsic value (DCF)6.73-68
Graham-Dodd Method0.00-100
Graham Formula0.00-100

Company description

AVTR is a leading global provider of healthcare and pharmaceutical solutions. The company was founded in 2019 following the merger of PharMEDium and B. Braun's CAPS, bringing together two established leaders in the industry. AVTR offers a wide range of services including compounding and supply chain solutions, along with innovative technologies to support patient care. The company operates in over 20 countries and serves a diverse customer base including hospitals, clinics, and retail pharmacies. With a focus on safety, quality, and reliability, AVTR aims to improve patient outcomes and provide cost-effective solutions to its clients. The company has a strong financial performance, with steady growth in revenue and profitability since its inception. AVTR also has a commitment to corporate responsibility and sustainability, working towards achieving a more equitable and sustainable world. As a leader in the healthcare industry, AVTR strives to continuously innovate and adapt to the ever-changing landscape, solidifying its position as a trusted and reliable partner in the healthcare community.